While Hepatitis C Virus (HCV) is a significant economic burden for healthcare providers, limited evidence is available on determinants of resources absorption, both in treatment-experienced and treatment-naïve HCV patients. The present study aimed to investigate the principal determinants of HCV management costs.4-8 November 201